Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-15

FDA Approved: OLINVYK — Supplemental Application (Trevena, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OLINVYK (oliceridine) from Trevena, Inc., to update the labeling as part of a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olinvyk (oliceridine)

Snippet

SUPPL AP for OLINVYK (OLICERIDINE)